Organization
Pediatric Cancer Center Barcelona
2 abstracts
Abstract
Patterns of improvement following initial response in patients treated with naxitamab for relapsed/refractory high-risk neuroblastoma.Org: Pediatric Cancer Center Barcelona, Hospital Sant Joan de Deu, Queen Mary Hospital and Hong Kong Children's Hospital, IRCCS Istituto Giannina Gaslini, Center for Pediatric and Adolescent Medicine,
Abstract
Reduction in Curie score in neuroblastoma patients treated with naxitamab.Org: Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Hong Kong Children's Hospital, The University of Hong Kong, The Hospital for Sick Children,